Natamycin
- Generic Name
- Natamycin
- Brand Names
- Natacyn
- Drug Type
- Small Molecule
- Chemical Formula
- C33H47NO13
- CAS Number
- 7681-93-8
- Unique Ingredient Identifier
- 8O0C852CPO
- Background
Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]
- Indication
For the treatment of fungal blepharitis, conjunctivitis, and keratitis caused by susceptible organisms including Fusarium solani keratitis.
- Associated Conditions
- Fungal blepharitis, Fungal conjunctivitis, Fungal infections of the cornea
- Associated Therapies
- -
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
- Conditions
- Acanthamoeba KeratitisFungal Keratitis
- Interventions
- First Posted Date
- 2021-11-05
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 330
- Registration Number
- NCT05110001
- Locations
- 🇮🇳
Aravind Eye Care System, Madurai, Tamil Nadu, India
🇧🇷Federal University of São Paulo, São Paulo, Brazil
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
- Conditions
- Fungal KeratitisCorneal Ulcer
- Interventions
- First Posted Date
- 2016-04-07
- Last Posted Date
- 2019-10-01
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 70
- Registration Number
- NCT02731638
- Locations
- 🇮🇳
Aravind Eye Hospitals, Pondicherry, Tamil Nadu, India
🇺🇸Francis I. Proctor Foundation at UCSF, San Francisco, California, United States
Mycotic Ulcer Treatment Trial I
- Conditions
- Eye Infections, FungalCorneal Ulcer
- Interventions
- First Posted Date
- 2009-10-16
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 323
- Registration Number
- NCT00996736
- Locations
- 🇮🇳
Aravind Eye Hospital, Pondicherry, Tamil Nadu, India
🇮🇳Aravind Eye Hospitals, Madurai, Tamil Nadu, India
🇺🇸Proctor Foundation, UCSF, San Francisco, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.